NEW YORK, March 10, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition Corp. (NASDAQ: LSACU), a blank check company targeting the biopharma, medical technology, digital health and healthcare services sectors, announced today that it closed its initial public offering of 6,000,000 units, upsized from 5,000,000 units, at a price of $10.00 per unit. The underwriters have been granted a 45-day option to purchase up to an additional 900,000 units offered by LifeSci Acquisition to cover over-allotments, if any. The units are listed on the NASDAQ Capital Market (“NASDAQ”) and began trading under the symbol “LSACU” on March 6, 2020. Each unit consists of one share of common stock and one redeemable warrant, with each warrant entitling the holder to purchase one-half of one share of common stock at a price of $11.50 per whole share. Once the shares of common stock and warrants begin separate trading, they are expected to be listed on NASDAQ under the symbols “LSAC,” and “LSACW,” respectively.

Chardan acted as sole book running manager for the offering.

About LifeSci Acquisition Corp.

LifeSci Acquisition Corp. (NASDAQ:LSACU) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company intends to pursue prospective targets that are focused on healthcare innovation in North America or Europe. For more information, please visit www.lifesciacquisition.com.